Drawing for SIMULX

USPTO serial 79262852

SIMULX

Reviewed by CopyMark Law Group

Reg. 6082359Status 700Renewal
Filing date
Status date
Registration date
Jun 23, 2020
Examiner
CHISOLM, KEVON
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SIMULX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. Bud Nelson

M. Bud Nelson Simulations Plus, Inc.800 Park Offices Dr, Ste 401Research Triangle Park, NC 27709United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable clinical and preclinical trial simulation software; downloadable software used to process and interpret diagnostic test results; downloadable software for collecting, storing and processing data, images, photographs, audio, visual and audio-visual data; downloadable database management software; all these goods intended for simulation of clinical or preclinical trials or for individual optimization of therapeutic treatmentsACTIVE—
042Pharmaceutical drug development services, namely, evaluations, assessments and research in the scientific, technological and medical fields provided by engineers; engineers' services involving evaluations, estimates, research and reporting in scientific, technological and medical fields, namely, design and development of drugs and medical devices, and in the fields of modeling, simulation, statistics and data analysis; medical and scientific research in the field of clinical trial simulation; laboratory services for scientific and medical research; conducting clinical trials for others; research and development of new products for third parties; technical project studies, namely, drug and medical devices discovery services, design and development of drugs, and modeling, simulation, statistics and data analysis; design and development of computers and software; design and development of computers and software for treatment optimization; research relating to software; development, design, installation, maintenance, updating and rental of software; programming for computers; providing information relating to medical research; assistance and consulting, namely, installation, administration, and troubleshooting of web and database applications in connection with the development of systems, databases and computer applications; conversion of computer programs and data, other than physical conversion; information, advice, and support services in the nature of troubleshooting of computer software problems relating to any of the aforementioned services; all these services intended for simulation of clinical or preclinical trials or for individual optimization of therapeutic treatmentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 13, 2026PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Oct 29, 2026EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Sep 17, 2026PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Sep 7, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 10, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
Jun 23, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 25, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 23, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 20, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 2, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 14, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 14, 2020FIMPFINAL DISPOSITION PROCESSED—
Sep 23, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 23, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 27, 2020CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
May 27, 2020LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
May 27, 2020LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Apr 17, 2020CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Apr 17, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Apr 7, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 4, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Mar 2, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 2, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 2, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 21, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 21, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 18, 2020ALIEASSIGNED TO LIE—
Feb 12, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 31, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jan 21, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 21, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 8, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 30, 2019RFNTREFUSAL PROCESSED BY IB—
Aug 14, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 14, 2019RFRRREFUSAL PROCESSED BY MPU—
Jul 20, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 17, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 16, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2019DOCKASSIGNED TO EXAMINER—
Jul 16, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 11, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance